FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Can AI match radiologists in prostate MRI diagnosis? The PARADIGM trial will assess AI detection of clinically significant ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

Patients in Leicestershire and Rutland now have access to a new state-of-the-art MRI scanner at the Leicester General ...

Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...

Full-body MRIs are all the rage. We take a look at three major companies offering such testing.

The drug makes prostate cancer easier to detect and stage because it attaches to the cancer cells themselves. This marks the third PSMA‑targeted radiopharmaceutical manufactured at Huntsman Cancer ...

Vanquish uses ultrasound, transurethral and electromagnetically guided thermotherapy to ablate prostate tissue.

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided ...

Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...

Certain cancers can now be frozen inside your body. Yes, you heard it right. In what could be a significant leap in minimally invasive oncology, Liverpool Hospi ...

New AI tool from UC San Diego and collaborators precisely maps the urethra on MRI to make prostate cancer radiation safer and reduce urinary side effects. Running on SDSC’s Expanse supercomputer, the ...